Patents by Inventor Miren Lorea Baroja

Miren Lorea Baroja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CD83 IN COMBINATION THERAPIES
    Publication number: 20230158109
    Abstract: The present invention relates to improved methods of suppressing and/or preventing an undesired immune response comprising the use of CD83. In some embodiments, CD83 is coadministered to a subject with at least one other immunosuppressive compound. Methods are also provided for generating tolerogenic dendritic cells and regulatory T cells. These cells can be used in vitro to produce additional cells for therapeutic purposes or they can be used in vivo to suppress and/or prevent an undesired immune response. Methods of the invention can be used to prevent or reduce the severity of autoimmune diseases and can also be used to induce tolerance to at least one therapeutic composition, such as a therapeutic protein or transplanted tissue.
    Type: Application
    Filed: June 10, 2022
    Publication date: May 25, 2023
    Inventors: Charles NICOLETTE, Stephen BRAND, Zhen ZHONG, Hao WANG, Jacqueline ARP, Siobhan RAMCHARRAN, Miren Lorea BAROJA
  • Use of CD83 in Combination Therapies
    Publication number: 20160324926
    Abstract: The present invention relates to improved methods of suppressing and/or preventing an undesired immune response comprising the use of CD83. In some embodiments, CD83 is coadministered to a subject with at least one other immunosuppressive compound. Methods are also provided for generating tolerogenic dendritic cells and regulatory T cells. These cells can be used in vitro to produce additional cells for therapeutic purposes or they can be used in vivo to suppress and/or prevent an undesired immune response. Methods of the invention can be used to prevent or reduce the severity of autoimmune diseases and can also be used to induce tolerance to at least one therapeutic composition, such as a therapeutic protein or transplanted tissue.
    Type: Application
    Filed: May 16, 2016
    Publication date: November 10, 2016
    Inventors: Charles Nicolette, Stephen Brand, Zhen Zhong, Hao Wang, Jacqueline Arp, Siobhan Ramcharran, Miren Lorea Baroja
  • Use of CD83 in Combination Therapies
    Publication number: 20160008440
    Abstract: The present invention relates to improved methods of suppressing and/or preventing an undesired immune response comprising the use of CD83. In some embodiments, CD83 is coadministered to a subject with at least one other immunosuppressive compound. Methods are also provided for generating tolerogenic dendritic cells and regulatory T cells. These cells can be used in vitro to produce additional cells for therapeutic purposes or they can be used in vivo to suppress and/or prevent an undesired immune response. Methods of the invention can be used to prevent or reduce the severity of autoimmune diseases and can also be used to induce tolerance to at least one therapeutic composition, such as a therapeutic protein or transplanted tissue.
    Type: Application
    Filed: October 1, 2015
    Publication date: January 14, 2016
    Inventors: Charles Nicolette, Stephen Brand, Zhen Zhong, Hao Wang, Jacqueline Arp, Siobhan Ramcharran, Miren Lorea Baroja